Browse > Article
http://dx.doi.org/10.15324/kjcls.2019.51.4.484

Relationship of Riboflavin and Niacin with Cardiovascular Disease  

Ahn, Ji Yeong (Department of Biomedical Laboratory Science, School of Medicine, Eulji University)
Kim, In Sik (Department of Biomedical Laboratory Science, School of Medicine, Eulji University)
Lee, Ji-Sook (Department of Clinical Laboratory Science, Wonkwang Health Science University)
Publication Information
Korean Journal of Clinical Laboratory Science / v.51, no.4, 2019 , pp. 484-494 More about this Journal
Abstract
Cardiovascular disease is caused by different factors. These factors include innateness factors such as aging, biological factors such as high blood pressure, and environmental factors such as stress. This study examined the factors associated with cardiovascular disease and the ways to reduce its prevalence by analyzing the data within the Korean National Health and Nutrition Examination Reports from 2013 to 2017, and particularly the survey and examination data for people over 50 years old. The study population was divided into two groups: members of the first group consumed riboflavin and niacin at the recommended rate while those in the second group did not. Riboflavin intake was correlated with hypertension, hyperglycemia, and a low HDL-cholesterol level, whereas niacin intake was correlated with hypertension, hyperglycemia, waist size, and a low HDL-cholesterol level. The combination of niacin and riboflavin intakes was correlated with hypertension, hyperglycemia, waist size, and a low HDL-cholesterol level (P<0.05). The combined intake of the recommended levels of riboflavin and niacin reduced the average physiological factor abnormality rate to 80%. Taken together, the beneficial effects of riboflavin and niacin can reduce the prevalence of cardiovascular disease.
Keywords
Riboflavin; Niacin; Cardiovascular disease;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Youn SI, Moun JS, Sin C, Park HY, Lee JB, Jo IH. SNP study of the endothelial NO Synthase as risk factor for cardiovascular diseases in Koreans. Report of National Institute of Health. 2000;37:400-404.
2 Lee SW, Kim HC, Suh HS, Suh I. Thirty-year trends in mortality from cardiovascular diseases in Korea. Korean Circ J. 2015;45:202-209.   DOI
3 Xu L, Ryu S, Goong H. Gender differences in predictors of health behaviors modification among patients with cardiovascular disease. JKCA. 2015;15:280-289.
4 Cho JJ, Kim JY, Byun JS. Occupational stress on risk factors for cardiovascular diseases and metabolic syndrome. Ann Occup Environ Med. 2006;18:209-220.
5 Jee SH, Song JW, Cho HK, Kim S, Jang YS, Kim JH. Development of the individualized health risk appraisal model of ischemic heart disease risk in Korea. J Lipid Atheroscler. 2004;14:153-168.
6 Hoppel C, Dimarco JP, Tandler B. Riboflavin and rat hepatic cell structure and function, mitochondrial oxidative metabolism in deficiency states. J Biol chem. 1979;254:4164-4170.   DOI
7 Sugioka G, Porta EA, Corey PN, Hartoft WS. The liver of rats fed riboflav in-deficient diet at two levels of protein. Am J Pathol. 1969;54:1-19.
8 Mielgo-Ayuso J, Aparicio-Ugarriza R, Otza J, Aranceta-Bartrina J, Gil A,Ortega RM. et al. Dietary intake and food sources of niacin, riboflavin, thiamin and vitamin B6 in a representative sample of the Spanish population. The ANIBES Study. Nutrients. 2018;10:846.   DOI
9 Zhang LH, Kamanna VS, Zhang MC, Kashyap ML. Niacin inhibits surface expression of ATP synthase ${\beta}$ chain in HepG2 cells: implications for raising HDL. J Lipid Res. 2008;49:1195-1201.   DOI
10 Braun MM, Stevens WA, Barstow CH. Stable coronary artery disease: treatment. Am Fam Physician. 2018;97:376-384.
11 Kim JS, Kim SS, Jung JK, Kim YD, Youn SJ, Kim JY, et al. Association of abdominal aortic calcification with lifestyle and risk factors of cardiovascular disease. Korean J Fam Med. 2013;34:213-220.   DOI
12 Ko HJ, Youn CH. The association between serum gamma-glutamyl transferase within normal range and risk factors of cardiovascular diseases: Based on the framingham risk score. Korean J Obes. 2013;22:261-263.   DOI
13 Pisarik P. Evidence supporting niacin therapy is more nuanced than article states. Am Fam Physician. 2018;98:630-631.
14 Choi JY, Kim YN, Cho YO. Evaluation of riboflavin intakes and status of 20-64-year-old adults in South Korea. Nutrients. 2015;7:253-264.   DOI
15 Kweon S, Kim Y, Jang MJ, Kim Y, Kim K, Choi S, et al. Data resource profile: the Korea National Health and Nutrition Examination Survey (KNHANES). Int J Epidemiol. 2014;43:69-77.   DOI
16 Korea Centers for Disease Control and Prevention. Metabolic syndrome [Internet] Cheongju: Korea Centers for Disease Control and Prevention; 2016 [cited by 2019 Oct 10]. Available from: http://health.cdc.go.kr/health/HealthInfoArea/HealthInfo/View.do?idx=490&page=1&sortType=date&dept=&category_code=&category=1&searchField=titleAndSummary&searchWord=&dateSelect=1&fromDate=&toDate=.
17 Ministry of Health. Dietary reference intakes for Koreans [Internet] Sejong: Ministry of Health; 2019 [cited by 2019 Ocyt 10]. Available from: http://www.mohw.go.kr/react/jb/sjb030301vw.jsp? PAR_MENU_ID=03&MENU_ID=032901&CONT_SEQ=337356.
18 Mendis S, Puska P, Norrving B. Global atlas on cardiovascular disease. Prevention and control. The World Health Organization in collaboration with the World Heart Federation and the World Stroke Organization. Geneva, Switzerland. 2011;1:1-153.
19 Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Heart disease and stroke statistics-2015 update a report from the American heart association. Circulation. 2015;131:E29-322.
20 Abramson BL, Melvin RG. Cardiovascular risk in women: focus on hypertension. Can J Cardiol. 2014;30:553-559.   DOI
21 Goff DC, Lloyd-Jones DM, Bennett G, Coady S, D'Agostino RB, Gibbons SR, et al. 2013 ACC /AHA guideline on the assessment of cardiovascular risk: A report of the American college of cardiology/American heart association task force on practice guidelines. J Am Coll Cardiol. 2014;1:2935-2959.
22 Peter SA, Huxley RR, Woodward M. Diabetes as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 64 cohorts, including 775,385 individuals and 12,539 strokes. Lancet. 2014;383:1973-1980.   DOI
23 Bae YH, Lee KW. Risk factors for cardiovascular disease in adults aged 30 years and older. Journal of The Korean Society of Integrative Medicine. 2016;4:97-107.   DOI
24 Toth PP, Barter PJ, Rosenson RS, Boden WE, Chapman MJ, Cuchel M, et al. High-density lipoproteins: A consensus statement from the national lipid association. J Clin Lipidol. 2013;7:484-525.   DOI
25 Ridker PM. LDL cholesterol: controversies and future therapeutic directions. Lancet. 2014;16:607-617.   DOI
26 Huxley R, Lewington S, Clarke R. Cholesterol, coronary heart disease and stroke: a review of published evidence from observational studies and randomized controlled trials. Semin Vasc Med. 2002;2:315-323.   DOI
27 Ragland DR, Brand RJ. Coronary heart disease mortality in the western collaborative group study, follow-up experience of 22 years. Am J Epidemiol. 1988;127:462-475.   DOI
28 Jeppesen J, Hein HO, Suadicani P, Gyntelberg F. Triglyceride concentration and ischemic heart disease: an eight-year follow-up in the copenhagen male study. Circulation. 1998;97:1029-1036.   DOI
29 Park JK, Kim HJ, Park KS, Lee SS, Chang SJ, Shin KC, et al. The case-control study on the risk factors of cerebrovascular diseases and coronary heart diseases. J Prev Med Public Health. 1996;29:639-655.
30 Sin SH, Lee TY. Associations of serum lipid profiles with incidence of ischemic heart diseases in Korean adults: Retrospective Cohort Study. Journal of Korea Academia-Industrial cooperation Society. 2012;13:2219-2231.   DOI
31 Jee SH, Song JW, Cho HK, Kim S, Jang YS, Kim JH. Development of the individualized health risk appraisal model of ischemic heart disease risk in Korea. J Lipid Atheroscler. 2004;14:153-168.
32 National Heart, Lung, and Blood Institute (NHLBI). Epidemiology and prevention of cardiovascular disease. Bethesda. 1994.
33 Choi MC, Song YH, Rhee SY, Woo JT. Frammingham risk scores by occupational group based on the 3rd Korean National Health and Nutrition Examination Survey. Ann Occup Environ Med. 2009;21:63-75.
34 National Health Insurance Corporation. Payment data of health insurance Korea 2006-2011 [Internet]. Wonju: National Health Insurance Corporation; 2019 [cited 2019 Oct 10]. Available from: https://www.nhis.or.kr/retrieveHomeMain.xx.
35 Patel A, Barzi F, Jamrozik K, Lam TH, Ueshima H, Whitlock G, et al. Serum triglycerides as a risk factor for cardiovascular diseases in the Asia-Pacific region. Circulation. 2004;110:2078-2086.
36 Cho EY, Bae SJ, Cho HK, Ko YG, Park HY, Lee JH, et al. Association of cholesteryl ester transfer protein gene polymorphism with serum lipid concentration and coronary artery disease in Korean men. Korean Circ J. 2004;34:565-573.   DOI
37 D'Andrea E, Hey SP, Ramirez CL, Kesselheim AS. Assessment of the role of niacin in managing cardiovascular disease outcomes: a systematic review and meta-analysis. JAMA Netw Open. 2019;2:E192224.   DOI
38 Carretero OA, Oparil S. Essential hypertension, part 1: definition and etiology. Circulation. 2000;101:329-335.   DOI
39 Cutler JA. High blood pressure and end-organ damage. J Hypertens Suppl. 1996;14:3-6.